Using a ‘depletive’ strategy reduces VAP incidence says a study using data from a previous trial on the benefit of BNP in weaning.
March 2014 archive
3 sepsis papers at once
1. First of the 3 attempts to confirm goal-directed therapy benefit, PROCESS, has arrived and shows no benefit of a protocolised approach ‘v’ usual care. Look carefully at the details, particularly at the protocol changes. 2. MAP targeting in septic shock. 65-70 or 80-85 mmHg? No mortality difference in 776 patients but less kidney injury …